Cyclotides are an abundant and diverse group of ribosomally synthesized plant peptides containing a cyclic cystine-knotted structure that confers them with remarkable stability. They are explored for their distribution in plants, although little is known about the individual peptide content of a single species. Therefore, we chemically analyzed the crude extract of the coffeefamily plant Oldenlandia affinis using a rapid peptidomics workflow utilizing nano-LC-MS, peptide reconstruct with database identification, and MS/MS automated sequence analysis to determine its cyclotide content. Biologically, cyclotides are mainly explored for applications in agriculture and drug design; here we report their growth-inhibiting effects on primary cells of the
ASSOCIATED CONTENT Supporting InformationSupplemental figures: Structural alignment of kalata B1 and B2 ( Figure S1), determination of IC 50 for antiproliferative effect of kalata B1 on PBMC ( Figure S2), and effects of melittin on cell proliferation and cytotoxicity on PBMC ( Figure S3). Supplemental table: Comparison of IC 50 values for kalata B1 on various cellular test systems (Table S1). Supplemental files: LC-MS reconstruct of O. affinis cyclotides (file S1), O. affinis database search results following digests and LC-MS/MS analysis (file S2), and cyclotide quantification data (file S3). This material is available free of charge via the Internet at http://pubs.acs.org.
Europe PMC Funders GroupAuthor Manuscript J Nat Prod. Author manuscript; available in PMC 2012 July 18.
Europe PMC Funders Author ManuscriptsEurope PMC Funders Author Manuscripts human immune system using biological and immunological end points in cell-based test systems. LC-MS quantification of the active O. affinis plant extract triggered the characterization of the antiproliferative activity of kalata B1, one of the most abundant cyclotides in this extract, on primary activated human lymphocytes. The effect has a defined concentration range and was not due to cytotoxicity, thus opening a new avenue to utilize native and synthetically optimized plant cyclotides for applications in immune-related disorders and as immunosuppressant peptides.The body's immune system is a powerful weapon against pathogens, but malfunctioning can cause an over-reactivity of this defense machinery and in some instances lead to autoimmune diseases such as rheumatoid arthritis (RA) or Crohn's disease. Immunosuppression, the targeted reduction of the activation or efficacy of the immune system, is an option for the treatment of these conditions. Because T-lymphocytes have the greatest impact during this defense response, most immunosuppressive medications aim to act on these cells. A representative is the drug cyclosporine A, a cyclic nonribosomal depsipeptide of fungal origin, which is the method of choice for severe cases of RA, 1,2 although it has many and sometimes severe side effects. 3Other naturally occurring circular peptides with potential pharmaceutical applications have been found in various organisms ...